1717 Langhorne Newtown Road
Suite 300
Langhorne, PA 19047
United States
(512) 614-1848
https://www.savarapharma.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 37
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Matthew Pauls J.D., M.B.A. | Chairman & CEO | 894.54k | N/A | 1971 |
Mr. David L. Lowrance CPA | CFO, Chief Administrative Officer & Secretary | 613.75k | N/A | 1968 |
Dr. Raymond Dennis Pratt FACP, M.D. | Chief Medical Officer | 91.89k | N/A | 1951 |
Mr. Robert Lutz M.B.A. | Chief Operating Officer | N/A | N/A | 1970 |
Ms. Kate McCabe J.D. | Senior VP & General Counsel | N/A | N/A | N/A |
Ms. Anne Erickson | Chief Business Officer | N/A | N/A | N/A |
Brian Maurer | Head of Clinical Operations | N/A | N/A | N/A |
Mr. Charles LaPree | Senior Vice President of Global Regulatory Affairs & Quality Assurance | N/A | N/A | N/A |
Dr. Peter Clarke Ph.D. | Executive Vice President of Global Technical Operations | N/A | N/A | 1960 |
Mr. Scott L. Wilhoit | Executive Vice President of Global Commercial | N/A | N/A | 1963 |
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.
Savara Inc.’s ISS Governance QualityScore as of April 1, 2024 is 4. The pillar scores are Audit: 4; Board: 6; Shareholder Rights: 1; Compensation: 7.